院前止血带使用:社区应用与结局评估
该研究为回顾性队列研究,描述华盛顿州金县2018年1月至2019年6月由急救医疗服务(EMS)处理的院前止血带使用情况。共168例患者接受止血带应用,发生率为每10万人年5.1例、每1000次创伤相关EMS出诊3.48例;穿透伤占64%、钝性伤占30%、动静脉瘘出血占7%。13%收缩压<90 mm Hg、8%格拉斯哥昏迷评分<13、3%心脏骤停;24%需大量输血、59%需急诊手术、21%需血管手术,死亡率3%(n=4)。出院时止血带肢体功能完全正常81%、部分功能10%、无功能9%,功能下降未归因于止血带应用。
要点
- 共168例院前止血带应用,发生率为每10万人年5.1例、每1000次创伤相关EMS出诊3.48例。
- 首次放置者:执法人员48%、公众33%、EMS 18%;穿透伤64%、钝性伤30%、动静脉瘘出血7%。
- 危重比例:13%收缩压<90 mm Hg,8%格拉斯哥昏迷评分<13,3%心脏骤停。
- 在公众或执法人员放置的137例中,EMS仅保留原止血带45%(n=61)、加放第二根20%(n=28)、拆除未替换35%(n=48)。
- 总体24%需大量输血、59%需急诊手术、21%需血管手术,死亡率3%(n=4);出院时止血带肢体功能完全正常81%、部分功能10%、无功能9%,功能下降未归因于止血带应用。
适用人群与场景
- 华盛顿州金县2018年1月至2019年6月由EMS处理的院前止血带应用患者,共168例。
- 损伤类型包括穿透伤64%、钝性伤30%、动静脉瘘出血7%。
红旗征与不能漏的情况
- 13%收缩压<90 mm Hg、8%格拉斯哥昏迷评分<13、3%心脏骤停,提示部分患者危重。
研究设计与关键结果
- 回顾性队列研究,168例院前止血带应用,发生率为每10万人年5.1例、每1000次创伤相关EMS出诊3.48例。
- 首次放置者:执法人员48%、公众33%、EMS 18%。
- 在公众或执法人员放置的137例中,EMS仅保留原止血带45%(n=61)、加放第二根20%(n=28)、拆除未替换35%(n=48)。
- 24%需大量输血、59%需急诊手术、21%需血管手术,死亡率3%(n=4)。
- 出院时止血带肢体功能完全正常81%、部分功能10%、无功能9%,功能下降未归因于止血带应用。
证据类型、等级与局限
- 证据类型:回顾性队列研究;证据等级:治疗性,Ⅳ级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,高应用率、部分患者需紧急院内干预以及明显并发症发生率低,提示增加止血带可及性和早期使用可带来公共卫生获益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: There is substantial investment in layperson and first responder training involving tourniquet use for hemorrhage control. Little is known however about prehospital tourniquet application, field conversion, or outcomes in the civilian setting. We describe the experience of a metropolitan region with prehospital tourniquet application.
METHODS: We conducted a retrospective cohort study characterizing prehospital tourniquet use treated by emergency medical services (EMS) in King County, Washington, from January 2018 to June 2019. Emergency medical services and hospital records were abstracted for demographics, injury mechanism, tourniquet details, clinical care, and outcomes. We evaluated the incidence of tourniquet application, who applied the device (EMS, law enforcement, or layperson), and subsequent course.
RESULTS: A total of 168 patients received tourniquet application, an incidence of 5.1 per 100,000 person-years and 3.48 per 1,000 EMS responses for trauma. Tourniquets were applied for penetrating trauma (64%), blunt trauma (30%), and bleeding ateriovenous fistulas (7%). A subset was critically ill: 13% had systolic blood pressures of <90 mm Hg, 8% had Glasgow Coma Scale score of <13, and 3% had cardiac arrest. Among initial applications, 48% were placed by law enforcement, 33% by laypersons, and 18% by EMS. Among tourniquets applied by layperson or law enforcement (n = 137), EMS relied solely on the original tourniquet in 45% (n = 61), placed a second tourniquet in 20% (n = 28), and removed the tourniquet without replacement in 35% (n = 48). Overall, 24% required massive transfusion, 59% underwent urgent surgery, and 21% required vascular surgery. Mortality was 3% (n = 4). At hospital discharge, the tourniquet limb was fully functional in 81%, partially functional in 10%, and nonfunctional in 9%; decreased function was not attributed to tourniquet application.
CONCLUSION: The high rate of application, need for urgent hospital intervention in a subset, and low incidence of apparent complication suggest that efforts to increase access and early tourniquet use can provide public health benefit.
LEVEL OF EVIDENCE: Therapeutic, level IV.
参考来源
- Barnard LM, Guan S, Zarmer L, et al. Prehospital tourniquet use: An evaluation of community application and outcome. J Trauma Acute Care Surg. 2021. PMID: 34016927. doi:10.1097/TA.0000000000003145
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。